Pipeline

We are advancing therapeutic candidates for the treatment of chronic HBV in multiple clinical trials as well as research programs focused on the discovery of additional novel antiviral mechanisms for HBV, and other viral diseases. More information about our clinical trials can be found at www.clinicaltrials.gov.